Merck KGaA
Darmstadt, Germany
Company
Expertise
Research
News
Careers
Investors
Main menu
Home
To Our Shareholders
To Our Shareholders
Letter from Belén Garijo
The Executive Board
Our Shares
In figures
Management Report
Management Report
Fundamental Information about the Group
Fundamental Information about the Group
Company Profile and Structure
Company Profile and Structure
Life Science
Healthcare
Electronics
Strategy
Strategy
Vision and Strategy Fundamentals
Business Strategies
Data & Digital Strategy
Sustainability Strategy
Strategic finance and dividend policy
Internal Management System
Internal Management System
Key performance indicators
Investments and value management
Capital market-related parameters
Relevant
non-financial
performance measures
Research and Development
Research and Development
Life Science
Healthcare
Electronics
Report on Economic Position
Report on Economic Position
Macroeconomic Environment
Review Forecast against Business Developments
Course of Business and Economic Position
Course of Business and Economic Position
Group
Life Science
Healthcare
Electronics
Corporate and Other
Report on Risks and Opportunities
Report on Risks and Opportunities
Business-related risks and opportunities
Financial risks and opportunities
Legal risks
Human resources risks
Information technology risks
Environmental,
climate-related,
and safety risks and opportunities
Management assessment
Report on Expected Developments
Report in accordance with section 315a HGB
Sustainability Statement
Sustainability Statement
General Disclosures
General Disclosures
Basics for preparation
Our governance
Our governance
The role of the administrative, management and supervisory bodies (GOV-1)
Information provided to and sustainability matters addressed by the administrative, management and supervisory bodies (GOV-2)
Integration of sustainability-related performance in incentive schemes (GOV-3)
Statement on due diligence (GOV-4)
Risk management and internal controls over sustainability reporting (GOV-5)
Our strategy
Our strategy
Strategy, business model and value chain (SBM-1)
Interests and views of stakeholders (SBM-2)
Material impacts, risks and opportunities and their interaction with our strategy and business model (SBM-3)
Our management of impacts, risks and opportunities
Our management of impacts, risks and opportunities
Description of the process to identify and assess material impacts, risks and opportunities (IRO-1)
Disclosure requirements in ESRS covered by the non-financial statement (IRO-2)
Environment
Environment
EU Taxonomy Regulation
Climate Change (E1)
Climate Change (E1)
After Lynx E1
after-lynx-e2
Pollution (E2)
Water and Marine Resources (E3)
Biodiversity and Ecosystems (E4)
Resource Use and Circular Economy (E5)
Social
Social
Own Workforce (S1)
Workers in the Value Chain (S2)
Consumers and End-Users (S4)
Governance
Governance
Business Conduct (G1)
Anti-Corruption and Anti-Bribery
Additional Information in Accordance with the German Commercial Code (HGB)
Corporate Governance
Corporate Governance
Compensation Report
Compensation Report
Review of fiscal 2024
Determining the compensation of the Executive Board
Overview of the structure of the compensation system
Executive Board compensation for 2024
Individual Disclosure of the Compensation of the Executive Board
Compensation for the Supervisory Board members
Comparative presentation of compensation and earnings development
Report of the Independent Auditor
Capital Structure and Corporate Bodies
Statement on Corporate Governance
Statement on Corporate Governance
Corporate governance practices
Procedures of the Executive Board, Supervisory Board, Board of Partners, and its Committees
Promote women in management positions
Diversity policy
Report of the Supervisory Board
Objectives of the Supervisory Board
Consolidated Financial Statements
Consolidated Financial Statements
Income Statement
Statement of Comprehensive Income
Balance Sheet
Cash Flow Statement
Statement of Changes in Net Equity
Notes
Notes
General Disclosures
General Disclosures
1.
Company information
2.
Reporting principles
3.
Discretionary decisions and sources of estimation uncertainty
4.
Subsequent events
Group Structure
Group Structure
5.
Scope of Consolidation
6.
Acquisitions and divestments
7.
Collaboration and licensing agreements
Operating Activities
Operating Activities
8.
Segment Reporting
9.
Net sales
10.
Cost of sales
11.
Marketing and selling expenses
12.
Research and development costs
13.
Other operating income
14.
Other operating expenses
15.
Income tax
16.
Operating cash flow
17.
Earnings per share
Operating Assets, Liabilities, and Contingent Liabilities
Operating Assets, Liabilities, and Contingent Liabilities
18.
Goodwill
19.
Other intangible assets
20.
Property, plant, and equipment
21.
Leasing
22.
Other non-financial assets
23.
Cash flow from investing activities
24.
Inventories
25.
Trade and other receivables
26.
Contract assets
27.
Other provisions
28.
Contingent liabilities
29.
Other non-financial liabilities
30.
Trade and other current payables
Employees
Employees
31.
Number of employees
32.
Personnel expenses
33.
Provisions for employee benefits
Capital Structure, Investments, and Financing Activities
Capital Structure, Investments, and Financing Activities
34.
Net equity
35.
Cash and cash equivalents
36.
Other financial assets
37.
Financial debt/capital management
38.
Other financial liabilities
39.
Derivative financial instruments
40.
Finance income and expenses/net gains and losses from financial instruments
41.
Cash flow from financing activities
42.
Management of financial risks
43.
Information on fair value measurement
44.
Other financial obligations
Other Disclosures
Other Disclosures
45.
Related party disclosures
46.
Executive Board and Supervisory Board compensation
47.
Auditor’s fees
Scope of Consolidation
Scope of Consolidation
48.
List of shareholdings
Other Information
Other Information
Responsibility Statement
Reproduction of the Independent Auditor’s Report
GRI content index
SASB index
TCFD report
Business Development 2020 – 2024
Financial Calendar
Annual Report 2024
To Our Shareholders
To Our Shareholders
Letter from Belén Garijo
The Executive Board
Our Shares
In figures
Management Report
Management Report
Fundamental Information about the Group
Fundamental Information about the Group
Company Profile and Structure
Company Profile and Structure
Life Science
Healthcare
Electronics
Strategy
Strategy
Vision and Strategy Fundamentals
Business Strategies
Data & Digital Strategy
Sustainability Strategy
Strategic finance and dividend policy
Internal Management System
Internal Management System
Key performance indicators
Investments and value management
Capital market-related parameters
Relevant
non-financial
performance measures
Research and Development
Research and Development
Life Science
Healthcare
Electronics
Report on Economic Position
Report on Economic Position
Macroeconomic Environment
Review Forecast against Business Developments
Course of Business and Economic Position
Course of Business and Economic Position
Group
Life Science
Healthcare
Electronics
Corporate and Other
Report on Risks and Opportunities
Report on Risks and Opportunities
Business-related risks and opportunities
Financial risks and opportunities
Legal risks
Human resources risks
Information technology risks
Environmental,
climate-related,
and safety risks and opportunities
Management assessment
Report on Expected Developments
Report in accordance with section 315a HGB
Sustainability Statement
Sustainability Statement
General Disclosures
General Disclosures
Basics for preparation
Our governance
Our governance
The role of the administrative, management and supervisory bodies (GOV-1)
Information provided to and sustainability matters addressed by the administrative, management and supervisory bodies (GOV-2)
Integration of sustainability-related performance in incentive schemes (GOV-3)
Statement on due diligence (GOV-4)
Risk management and internal controls over sustainability reporting (GOV-5)
Our strategy
Our strategy
Strategy, business model and value chain (SBM-1)
Interests and views of stakeholders (SBM-2)
Material impacts, risks and opportunities and their interaction with our strategy and business model (SBM-3)
Our management of impacts, risks and opportunities
Our management of impacts, risks and opportunities
Description of the process to identify and assess material impacts, risks and opportunities (IRO-1)
Disclosure requirements in ESRS covered by the non-financial statement (IRO-2)
Environment
Environment
EU Taxonomy Regulation
Climate Change (E1)
Pollution (E2)
Water and Marine Resources (E3)
Biodiversity and Ecosystems (E4)
Resource Use and Circular Economy (E5)
Social
Social
Own Workforce (S1)
Workers in the Value Chain (S2)
Consumers and End-Users (S4)
Governance
Governance
Business Conduct (G1)
Anti-Corruption and Anti-Bribery
Additional Information in Accordance with the German Commercial Code (HGB)
Corporate Governance
Corporate Governance
Compensation Report
Compensation Report
Review of fiscal 2024
Determining the compensation of the Executive Board
Overview of the structure of the compensation system
Executive Board compensation for 2024
Individual Disclosure of the Compensation of the Executive Board
Compensation for the Supervisory Board members
Comparative presentation of compensation and earnings development
Report of the Independent Auditor
Capital Structure and Corporate Bodies
Statement on Corporate Governance
Statement on Corporate Governance
Corporate governance practices
Procedures of the Executive Board, Supervisory Board, Board of Partners, and its Committees
Promote women in management positions
Diversity policy
Report of the Supervisory Board
Objectives of the Supervisory Board
Consolidated Financial Statements
Consolidated Financial Statements
Income Statement
Statement of Comprehensive Income
Balance Sheet
Cash Flow Statement
Statement of Changes in Net Equity
Notes
Notes
General Disclosures
General Disclosures
1.
Company information
2.
Reporting principles
3.
Discretionary decisions and sources of estimation uncertainty
4.
Subsequent events
Group Structure
Group Structure
5.
Scope of Consolidation
6.
Acquisitions and divestments
7.
Collaboration and licensing agreements
Operating Activities
Operating Activities
8.
Segment Reporting
9.
Net sales
10.
Cost of sales
11.
Marketing and selling expenses
12.
Research and development costs
13.
Other operating income
14.
Other operating expenses
15.
Income tax
16.
Operating cash flow
17.
Earnings per share
Operating Assets, Liabilities, and Contingent Liabilities
Operating Assets, Liabilities, and Contingent Liabilities
18.
Goodwill
19.
Other intangible assets
20.
Property, plant, and equipment
21.
Leasing
22.
Other non-financial assets
23.
Cash flow from investing activities
24.
Inventories
25.
Trade and other receivables
26.
Contract assets
27.
Other provisions
28.
Contingent liabilities
29.
Other non-financial liabilities
30.
Trade and other current payables
Employees
Employees
31.
Number of employees
32.
Personnel expenses
33.
Provisions for employee benefits
Capital Structure, Investments, and Financing Activities
Capital Structure, Investments, and Financing Activities
34.
Net equity
35.
Cash and cash equivalents
36.
Other financial assets
37.
Financial debt/capital management
38.
Other financial liabilities
39.
Derivative financial instruments
40.
Finance income and expenses/net gains and losses from financial instruments
41.
Cash flow from financing activities
42.
Management of financial risks
43.
Information on fair value measurement
44.
Other financial obligations
Other Disclosures
Other Disclosures
45.
Related party disclosures
46.
Executive Board and Supervisory Board compensation
47.
Auditor’s fees
Scope of Consolidation
Scope of Consolidation
48.
List of shareholdings
Other Information
Other Information
Responsibility Statement
Reproduction of the Independent Auditor’s Report
GRI content index
SASB index
TCFD report
Business Development 2020 – 2024
Financial Calendar
en
Suche
Hauptmenü
Interactive Chart Generator
Services
Chart Generator
Downloads
Feedback
Share this page:
E-Mail
Facebook
Twitter
LinkedIn